CCR5 Ligands in HIV Vaccines

Figure 2. Time course production of chemokine production in response to antigen activation. (A): Production of RANTES, MIP-10, and MIP- 1f between dayl and day 3 after stimulation. (B): production of MIP-la, and (C): production of MIP-lb within the first 24 hours of stimulation. N=4 (different donors were used for (A) as opposed to (B) and (C). 5000 4500 E 4000 3500 3000 2500 2000 1500 E 1000 500 0 14000 S 12000 [1] t=2hrs(B ) p, 10000 [t=4hrs 8000 6000 - 0= 4h s c 4000 2000 0 Control TTx 10ug/ml Candida 1Oug/m 1 14000 12000 ]t=2hrs t0=4 hrs 10000 11t=8hrs 8000 - t=20hrs 6000 - t=24hrs 4000 2000 0 nf (C) lrrrlJ1 Control TTx lOug/ul Candida lOug/mI

/ 23

Actions

file_download Download Options Download this page PDF - Pages #1-23 Image - Page 20 Plain Text - Page 20

About this Item

Title
CCR5 Ligands in HIV Vaccines
Author
Garzino-Demo, Alfredo
Canvas
Page 20
Publication
undated
Subject terms
proposals
Item type:
proposals

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0230.031
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0230.031/21

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0230.031

Cite this Item

Full citation
"CCR5 Ligands in HIV Vaccines." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0230.031. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.